A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression.

Saha, Arka; Cheriyamundath, Sanith; Kumar, Anmol; Gavert, Nancy; Brabletz, Thomas; Ben-Ze'ev, Avri

Saha, Arka; Cheriyamundath, Sanith; Kumar, Anmol; Gavert, Nancy; Brabletz, Thomas; Ben-Ze'ev, Avri.

Afiliação

Saha A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Cheriyamundath S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Kumar A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Gavert N; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Brabletz T; Department of Experimental Medicine I, Nikolaus-Feibiger-Center for Molecular Medicine, University of Erlangen-Nuernberg, 91054 Erlangen, Germany.
Ben-Ze'ev A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.

Int J Mol Sci ; 23(1)2021 Dec 31.

Article em En | MEDLINE | ID: mdl-35008869

Assuntos

Biglicano/metabolismo; Moléculas de Adesão Celular/metabolismo; Neoplasias Colorretais/metabolismo; NF-kappa B/metabolismo; Animais; Adesão Celular; Linhagem Celular Tumoral; Movimento Celular; Humanos; Masculino; Camundongos; Camundongos Nus

Palavras-chave

L1CAM (L1); NF-κB; biglycan; colorectal cancer (CRC)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Moléculas de Adesão Celular / NF-kappa B / Biglicano Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google